Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2003
09/18/2003WO2003076902A2 Multiplex detection of biological materials in a sample
09/18/2003WO2003076899A2 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
09/18/2003WO2003076898A2 Mycobacterial diagnostics
09/18/2003WO2003076892A2 Device and methods for measuring the response of at least one cell to a medium
09/18/2003WO2003076667A1 Amplification-hybridisation method for detecting and typing human papillomavirus
09/18/2003WO2003076666A1 Compositions and methods for detecting nucleic acid methylation
09/18/2003WO2003076665A1 Hybridization assays for gene dosage analysis
09/18/2003WO2003076664A1 Antisense modulation of jagged 2 expression
09/18/2003WO2003076663A1 Detection of proteins interactions
09/18/2003WO2003076662A1 Identification of microbial polynucleotides expressed during infection of a host
09/18/2003WO2003076661A1 Apparatus and method for amplifying a polynucleotide
09/18/2003WO2003076660A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors
09/18/2003WO2003076659A2 Facl4 and mutation thereof on x-linkend mental retardation syndrome
09/18/2003WO2003076658A2 A susceptibility gene for late-onset idiopathic parkinson's disease
09/18/2003WO2003076657A2 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes
09/18/2003WO2003076656A2 Use of capturing probes for identifying nucleic acids
09/18/2003WO2003076655A2 Method for identifying a nucleic acid analyte
09/18/2003WO2003076654A2 Method for identifying, quantifying and/or characterizing an analyte
09/18/2003WO2003076653A2 Dna conformational switches as sensitive electronic sensors of analytes
09/18/2003WO2003076652A1 Reagent for measuring alanine aminotransferase activity
09/18/2003WO2003076651A2 Cancer associated araf1 protein kinase and its uses
09/18/2003WO2003076650A1 Method for identifying enzymes with activity on insoluble substrates
09/18/2003WO2003076648A1 Amperometric thick-film biosensor for determining the hydrogen peroxide concentration in a solution and a method for producing said sensor
09/18/2003WO2003076641A2 Method of detecting and quickly identifying pathogenic bacteria that can be transmitted through food using the real-time polymerase chain reaction
09/18/2003WO2003076631A2 Genetic products differentially expressed in tumors and use thereof
09/18/2003WO2003076628A1 Scytalone dehydrogenase gene showing tolerance to agricultural pesticide
09/18/2003WO2003076624A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
09/18/2003WO2003076623A1 Cdc7-ASK KINASE COMPLEX, SUBSTRATE OF THE KINASE COMPLEX, ANTIBODY SPECIFIC TO THE SUBSTRATE, AND METHOD OF SCREENING COMPOUND CAPABLE OF INHIBITING Cdc7-ASK KINASE USING THE SAME
09/18/2003WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene
09/18/2003WO2003076615A1 Novel method of highly sensitive nucleic acid analysis
09/18/2003WO2003076614A1 Method of collecting data for deducing sensitivity to periodontal disease
09/18/2003WO2003076610A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
09/18/2003WO2003076608A1 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
09/18/2003WO2003076606A1 High throughput system for producing recombinant viruses using site-specific recombination
09/18/2003WO2003076596A2 Altering viral tropism
09/18/2003WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003WO2003076593A2 Genomic screen for epigenetically silenced genes associated with cancer
09/18/2003WO2003076589A2 Analysis of apoptotic bodies in bodily fluids
09/18/2003WO2003076586A2 Nucleic acid-associated proteins
09/18/2003WO2003076579A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076573A2 Quantitative trait loci and somatostatin
09/18/2003WO2003076571A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003WO2003076566A2 Enzymatic ligation-based identification of nucleotide sequences
09/18/2003WO2003076467A1 Compositions and methods for inducing and regulating bone formation
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076333A2 Crystalline structure of human mapkap kinase-2
09/18/2003WO2003076082A2 Surface-energy gradient on a fluid-impervious surface and method of its creation using a mixed monolayer film
09/18/2003WO2003076037A2 Selective elution of immobilized multiplexed primer extension products
09/18/2003WO2003075948A1 NOVEL FUNCTION OF Wnt AND APPLICATION THEREOF TO TREATMENT OF DISEASES
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075854A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003075844A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
09/18/2003WO2003075838A2 Methods and compositions for pharmacological and toxicological evaluation of test agents
09/18/2003WO2003075837A2 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof
09/18/2003WO2003075833A2 Screening method for orthopoxvirus antivirals
09/18/2003WO2003075751A2 Overfeeding methods for determining therapeutic strategies and/or targets for obesity therapeutics
09/18/2003WO2003075747A2 Contrast agents for magnetic resonance imaging and methods related thereto
09/18/2003WO2003062468A3 Method for binding site identification using a multi-scale approach
09/18/2003WO2003062445A3 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
09/18/2003WO2003054159A3 Modulating insulin receptor signaling through targeting facl
09/18/2003WO2003048735A3 Processes for the measurement of the potency of glatiramer acetate
09/18/2003WO2003046135A3 Osteopontin-related compositions and methods
09/18/2003WO2003038082A3 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants
09/18/2003WO2003038056A3 Methods for inhibiting lentivirus replication
09/18/2003WO2003036303A8 Diagnostic method
09/18/2003WO2003033736A3 Fine mapping and application of dna markers linked to a gall midge resistance gene for marker-aided selection in rice
09/18/2003WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
09/18/2003WO2003023389A9 Solid electrochemical sensor
09/18/2003WO2003023013A3 Novel nucleic acids and polypeptides
09/18/2003WO2003020974A3 Methods for detecting dna originating from different individuals in one sample
09/18/2003WO2003014722B1 Nucleic acid field effect transistor
09/18/2003WO2003014389A3 Method for determining susceptibility to prion disease
09/18/2003WO2003012139A3 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene
09/18/2003WO2003012113A3 Inducible expression systems employing ppar transcriptional activators
09/18/2003WO2003008639A3 Method for detecting a nucleic acid
09/18/2003WO2003004692A3 Screening processes for agents modulating cholesterol levels
09/18/2003WO2002099423A3 Method for determining an analyte
09/18/2003WO2002099129A3 Designing degenerate pcr primers
09/18/2003WO2002097125A3 Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases
09/18/2003WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
09/18/2003WO2002095070A3 Polynucleotide sequencing method
09/18/2003WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
09/18/2003WO2002072790A3 Tsg101-gag interaction and use thereof
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002059367A3 Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
09/18/2003WO2002050609A3 Electrochemical test strip cards that include an integral dessicant
09/18/2003WO2002046452A3 Method for quantifying cytosine methylations in genomic dna that is amplified in a complex manner
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003WO2002032929A3 Haplotypes of the cer1 gene
09/18/2003WO2002030571A3 Surface adsorbing polymers and the uses thereof to treat hydrophobic or hydrophilic surfaces
09/18/2003WO2002025284A3 High-throughput assays for the proteolytic activities of clostridial neurotoxins
09/18/2003WO2002006536A3 Methods and compositions for perioperative genomic profiling
09/18/2003WO2002004686A3 Detecting methylated cytosine in polynucleotides